Stock Research for CGIX


Featured Broker: Ally Invest

Get the due diligence for another stock.


CGIX Stock Chart & Research Data

The CGIX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CGIX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


CGIX Due diligence Resources & Stock Charts

The CGIX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CGIX Detailed Price Forecast - CNN Money CNN View CGIX Detailed Summary - Google Finance
Yahoo View CGIX Detailed Summary - Yahoo! Finance Zacks View CGIX Stock Research & Analysis -

Stock Analysis

TradeIdeas View CGIX Trends & Analysis - Trade-Ideas Barrons View CGIX Major Holders - Barrons
NASDAQ View CGIX Call Transcripts - NASDAQ Seeking View CGIX Breaking News & Analysis - Seeking Alpha
Spotlight View CGIX Annual Report - OTC Report View CGIX OTC Short Report -
TradeKing View CGIX Fundamentals - TradeKing Charts View CGIX SEC Filings - Bar Chart
WSJ View Historical Prices for CGIX - The WSJ Morningstar View Performance/Total Return for CGIX - Morningstar
MarketWatch View the Analyst Estimates for CGIX - MarketWatch CNBC View the Earnings History for CGIX - CNBC
StockMarketWatch View the CGIX Earnings - StockMarketWatch MacroAxis View CGIX Buy or Sell Recommendations - MacroAxis
Bullish View the CGIX Bullish Patterns - American Bulls Short Pains View CGIX Short Pain Metrics -

Social Media Mentions

StockTwits View CGIX Stock Mentions - StockTwits PennyStocks View CGIX Stock Mentions - PennyStockTweets
Twitter View CGIX Stock Mentions - Twitter Invest Hub View CGIX Investment Forum News - Investor Hub
Yahoo View CGIX Stock Mentions - Yahoo! Message Board Seeking Alpha View CGIX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for CGIX - Insider Cow View Insider Transactions for CGIX - Insider Cow
CNBC View CGIX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CGIX - OTC Markets
Yahoo View Insider Transactions for CGIX - Yahoo! Finance NASDAQ View Institutional Holdings for CGIX - NASDAQ

Stock Charts

FinViz View CGIX Stock Insight & Charts - StockCharts View CGIX Investment Charts -
BarChart View CGIX Stock Overview & Charts - BarChart Trading View View CGIX User Generated Charts - Trading View

Latest Financial News for CGIX

Edited Transcript of CGIX earnings conference call or presentation 15-May-18 12:30pm GMT
Posted on Tuesday June 19, 2018

Q1 2018 Cancer Genetics Inc Earnings Call

Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer
Posted on Tuesday June 12, 2018

Cancer Genetics, Inc. (CGIX), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced the appointment Michael McCartney as the Company’s Chief Commercial Officer, effective immediately. Mr. McCartney will be responsible for developing and overseeing Cancer Genetics’ commercial strategy and spearheading the Company’s business development initiatives.

Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Cancer Genetics, Inc. (CGIX)
Posted on Monday June 04, 2018

Glancy Prongay & Murray LLP (“GPM”) reminds investors of the June 4, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Cancer Genetics, Inc. (“Cancer Genetics” or the “Company”) (NASDAQ: CGIX) securities between March 23, 2017, and April 2, 2018, inclusive (the “Class Period”). To obtain information or actively participate in the class action, please visit the Cancer Genetics page on our website at Investors suffering losses on their Cancer Genetics investments are encouraged to contact Lesley Portnoy of GPM to discuss their legal rights in this class action at 310-201-9150 or by email to

DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Cancer Genetics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
Posted on Monday June 04, 2018

LOS ANGELES, CA / ACCESSWIRE / June 4, 2018 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Cancer Genetics, Inc. ("Cancer Genetics" or ''the Company'') (NASDAQ: CGIX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between March 23, 2017 and April 2, 2018, inclusive (the ''Class Period''), are encouraged to contact the firm before June 4, 2018.

Enter a stock symbol to view the stock details.